SCHEMBL4347205

SCHEMBL4347205

O=C(NCC1CCCCC1)N(S)c1cc(Br)cc(F)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 1/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 1/20 0.39
BCL2 P10415 1/20 0.38
BCL2L1 Q07817 1/20 0.38
MCL1 Q07820 1/20 0.38
BCL2A1 Q16548 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
MMP8 P22894 1/20 0.37
CA9 Q16790 1/20 0.37
POLB P06746 1/20 0.37
HDAC6 Q9UBN7 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4348879 0.82 ADORA2A (0.43) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL4349504 0.81 NPC1 (0.39) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL4359843 0.81 NPC1 (0.42) MEN1KMT2ANPC1RAB9ABCL2
SCHEMBL4347008 0.80 NPC1 (0.40) NPC1RAB9ABCL2BCL2L1MCL1
SCHEMBL4349769 0.78 MEN1 (0.43) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL4353771 0.77 NPC1 (0.42) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL4342426 0.77 NPC1 (0.40) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL4350334 0.76 EPHX1 (0.48) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL4347670 0.75 NPC1 (0.43) MEN1KMT2ANPC1RAB9ABCL2
SCHEMBL4349401 0.73 MGLL (0.38) MEN1KMT2AEPHX1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 MEN1 2168/4885KMT2A 2096/4885ALDH1A1 2565/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 MEN1 3901/4885KMT2A 1254/4885ALDH1A1 2767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.